Monday, Aug 10, 2026 · SEC filings
What the smart money revealed on Aug 10
462 insider filings came in. We hid 61 planned (10b5-1) sellers and 242 people whose filings were routine, like grants and tax withholding.
3 insiders at BlossomHill Therapeutics (BLSM) bought $182K of stock
Roles: CFO, General Counsel, Director. Several insiders buying in the same few days is rare.
51Talk Online Education Group (COE) CEO Jack Huang bought $13.8M
740,760 shares on the open market. Not a grant or an option exercise.
Latigo Biotherapeutics (LTGO) Director James Tananbaum bought $2.52M
140,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Fortune Brands Innovations (FBIN) CEO Jesse Singh bought $2.02M
39,285 shares on the open market. Not a grant or an option exercise.
Clarivate (CLVT) Director Kenneth Cornick bought $1.67M
900,000 shares on the open market. Not a grant or an option exercise.
Sanders Capital filed its holdings: 47 stocks
Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.
Flossbach Von Storch SE filed its holdings: 105 stocks
Holdings as of Jun 30, 2026. Open the fund to see what it bought and sold.
Primo Brands (PRMB) Director Tony Lee sold $497M
Not marked as a planned 10b5-1 sale. Sold 18% of the shares they held directly. Still holds 95.8M shares.
Black Stone Minerals (BSM) Director James Whitehead sold $28.1M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
BlueLinx (BXC) Director Kim Fennebresque sold $2.87M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
13F season
Holdings as of Jun 30, 2026 are due Aug 14
8,899 funds have filed so far. 8,900 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Aug 10.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.